Edition:
United Kingdom

Loxo Oncology Inc (LOXO.OQ)

LOXO.OQ on NASDAQ Stock Exchange Global Market

85.85USD
16 Jan 2018
Change (% chg)

-- (--)
Prev Close
$85.85
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
168,831
52-wk High
$95.78
52-wk Low
$36.79

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -2.454
Jun '17 0.00 -1.143
Mar '17 0.00 -0.956
FY 2016 Dec '16 0.00 -1.260
Sep '16 0.00 -0.819
Jun '16 0.00 -0.773
Mar '16 0.00 -0.593
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 4 0.00 0.00 0.00 0.00
Quarter Ending Jun-18 4 2.50 10.00 0.00 0.00
Year Ending Dec-18 6 36.08 53.00 6.85 54.90
Earnings (per share)
Quarter Ending Mar-18 5 -0.78 0.75 -1.32 -1.22
Quarter Ending Jun-18 5 -1.00 0.36 -1.56 -1.39
Year Ending Dec-18 7 -4.28 2.23 -7.39 -3.75
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 207.59 36.90
P/E High - Last 5 Yrs. -- 268.76 45.68
P/E Low - Last 5 Yrs. -- 92.22 24.26
Beta 2.41 0.82 0.88
Price to Sales (TTM) -- 141.70 6.58
Price to Book (MRQ) 6.52 26.37 5.79
Price to Tangible Book (MRQ) 6.52 31.46 7.43
Price to Cash Flow (TTM) -- 119.66 25.31
% Owned Institutions -- 7.80 1.86

Dividends

  Company industry sector
Dividend Yield -- 0.32 1.46
Dividend Yield - 5 Year Avg -- 0.24 2.03
Dividend 5 Year Growth Rate -- 1.89 5.32
Payout Ratio(TTM) -- 87.43 45.96

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -9.37 6.77
Sales (TTM) vs TTM 1 Yr. Ago -- 29.87 6.98
Sales - 5 Yr. Growth Rate -- 33.26 10.31
EPS (MRQ) vs Qtr. 1 Yr. Ago -199.81 -147.61 7.71
EPS (TTM) vs TTM 1 Yr. Ago -100.47 -- --
EPS - 5 Yr. Growth Rate -- 44.26 11.11
Capital Spending - 5 Yr. Growth Rate -- 40.80 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.55
Current Ratio (MRQ) 21.56 5.61 3.56
LT Debt to Equity (MRQ) 0.00 18.69 13.94
Total Debt to Equity (MRQ) 0.00 21.32 20.02
Interest Coverage (TTM) -- -136.72 35.70

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 45.94 54.98
Gross Margin - 5 Yr. Avg. -- 56.54 52.60
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -210.54 15.30
Operating Margin (TTM) -- -620.02 5.68
Operating Margin - 5 Yr. Avg. -- -229.66 10.55
Pre-Tax Margin (TTM) -- -589.98 6.55
Pre-Tax Margin - 5 Yr. Avg. -- -231.51 10.95
Net Profit Margin (TTM) -- -588.69 2.79
Net Profit Margin - 5 Yr. Avg. -- -235.23 7.23
Effective Tax Rate (TTM) -- 15.56 24.25
Effective Tax Rate - 5 Yr. Avg. -- 18.51 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,324,041 838,511,530
Net Income/Employee (TTM) -5,360,069 -2,172,005 97,909,667
Receivable Turnover (TTM) -- 25.82 6.15
Inventory Turnover (TTM) -- 2.63 3.54
Asset Turnover (TTM) 0.00 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -54.26 -8.74 11.22
Return on Assets - 5 Yr. Avg. -- 0.56 12.19
Return on Investment (TTM) -56.64 -11.19 14.28
Return on Investment - 5 Yr. Avg. -- 3.28 15.96
Return on Equity (TTM) -56.64 -33.91 15.94
Return on Equity - 5 Yr. Avg. -- 6.28 17.22
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -63.08 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Loxo Oncology Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 213
Total Shares Held: 30,209,517
3 Mo. Net Change: -703,861
# New Positions: 2
# Closed Positions: 4
# Increased Positions: 11
# Reduced Positions: 10
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.